Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CRISPR Therapeutics AG | 94,308 | reported | 23 Mar 2026 | tx 108+1,002,767−251,612 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 17,000 | 0.00 USD | deriv |
| 20 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 6,250 | — | |
| 23 Mar 2026 | SALE | CRISPR Therapeutics AG | 3,182 | 46.78 USD | |
| 20 Mar 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 38,499 | 0.00 USD | deriv |
| 20 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 6,250 | — | deriv |
| 20 Mar 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 25,000 | 0.00 USD | deriv |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 6,875 | — | |
| 16 Mar 2026 | SALE | CRISPR Therapeutics AG | 3,450 | 48.26 USD | |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 6,875 | — | deriv |
| 11 Mar 2026 | SALE | CRISPR Therapeutics AG | 2,800 | 52.80 USD | |
| 10 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 5,500 | — | |
| 10 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 5,500 | — | deriv |
| 18 Feb 2026 | EXERCISE | CRISPR Therapeutics AG | 3,825 | — | |
| 19 Feb 2026 | SALE | CRISPR Therapeutics AG | 2,112 | 52.58 USD | |
| 18 Feb 2026 | EXERCISE | CRISPR Therapeutics AG | 3,825 | — | deriv |
| 14 Oct 2025 | SALE | CRISPR Therapeutics AG | 1,076 | 66.60 USD | |
| 13 Oct 2025 | EXERCISE | CRISPR Therapeutics AG | 2,114 | — | |
| 13 Oct 2025 | EXERCISE | CRISPR Therapeutics AG | 2,114 | — | deriv |
| 03 Oct 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 16,500 | 0.00 USD | deriv |
| 20 Mar 2025 | EXERCISE | CRISPR Therapeutics AG | 6,250 | — | |
| 21 Mar 2025 | SALE | CRISPR Therapeutics AG | 3,185 | 41.23 USD | |
| 20 Mar 2025 | EXERCISE | CRISPR Therapeutics AG | 6,250 | — | deriv |
| 14 Mar 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 36,666 | 0.00 USD | deriv |
| 14 Mar 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 27,500 | 0.00 USD | deriv |
| 12 Mar 2025 | SALE | CRISPR Therapeutics AG | 1,116 | 43.32 USD |